Inventor · disambiguated record
John Thomas Feutrill
Also filed as: FEUTRILL JOHN · FEUTRILL JOHN T · FEUTRILL JOHN THOMAS
25 granted patents·7 pending applications·122 citations·filing 2008–2022
94Inventor score
Files withKALA PHARMACEUTICALS INC9YM BIOSCIENCES AUSTRALIA PTY4CATALYST THERAPEUTICS PTY LTD3CEDILLA THERAPEUTICS INC2Anaxis Pharma Pty Ltd1
Top patents by PatentIndex Score
32 records- 0195US8486941B2Phenyl amino pyrimidine compounds and uses thereofBURNS CHRISTOPHER JOHN·Filed 2008·Granted Jul 16, 2013·80 cites·17 claims
- 0287US9580421B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2015·Granted Feb 28, 2017·4 cites·20 claims
- 0387US8354408B2N-containing heterocyclic compoundsYM BIOSCIENCES AUSTRALIA PTY·Filed 2008·Granted Jan 15, 2013·13 cites·22 claims
- 0483US9238628B2Phenyl amino pyrimidine compounds and uses thereofYM BIOSCIENCES AUSTRALIA PTY·Filed 2013·Granted Jan 19, 2016·5 cites·2 claims
- 0582US9212145B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Dec 15, 2015·3 cites·80 claims
- 0679US10059693B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 28, 2018·1 cites·29 claims
- 0779US10059692B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 28, 2018·1 cites·31 claims
- 0878US9802922B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Oct 31, 2017·1 cites·12 claims
- 0978US8765755B2N-containing heterocyclic compoundsYM BIOSCIENCES AUSTRALIA PTY·Filed 2012·Granted Jul 1, 2014·4 cites·9 claims
- 1076US9040549B2Thiopyrimidine-based compounds and uses thereofCYTOPIA RES PTY LTD·Filed 2013·Granted May 26, 2015·4 cites·10 claims
- 1174US11352343B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2020·Granted Jun 7, 2022·0 cites·21 claims
- 1274US9499560B2N-containing heterocyclic compoundsYM BIOSCIENCES AUSTRALIA PTY·Filed 2014·Granted Nov 22, 2016·2 cites·16 claims
- 1371US10723719B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Jul 28, 2020·0 cites·20 claims
- 1468US10329280B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Jun 25, 2019·0 cites·20 claims
- 1568US10316022B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·0 cites·18 claims
- 1665US9233934B2Phenyl amino pyrimidine compounds and uses thereofYM BIOSCIENCES AUTRALIA PTY LTD·Filed 2013·Granted Jan 12, 2016·1 cites·5 claims
- 1763US9249085B2Aniline derivatives, their preparation and their therapeutic applicationFEUTRILL JOHN·Filed 2012·Granted Feb 2, 2016·1 cites·28 claims
- 1862US9242993B2Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mTOR inhibitorsCELLZOME LTD·Filed 2012·Granted Jan 26, 2016·1 cites·15 claims
- 1962US8846704B2Thiopyrimidine-based compounds and uses thereofBOURKE DAVID GERARD·Filed 2008·Granted Sep 30, 2014·1 cites·10 claims
- 2056US2024376046A1Phenyl-sulfamoyl-benzoic acid derivatives as erap1- modulatorsGREY WOLF THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2154US2021309615A1Phenyl amino pyrimidine compounds and uses thereofYM BIOSCIENCES AUSTRALIA PTY LTD C/O GILEAD SCIENCES INC·Filed 2015·Application pending·0 cites
- 2251US2024368173A1Tricyclic gpr65 modulatorsPATHIOS THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2348US12053459B2CDK2 inhibitors and methods of using the sameCEDILLA THERAPEUTICS INC·Filed 2022·Granted Aug 6, 2024·0 cites·23 claims
- 2445US12065445B2CDK2 inhibitors and methods of using the sameCEDILLA THERAPEUTICS INC·Filed 2022·Granted Aug 20, 2024·0 cites·38 claims
- 2545US9624159B2Aniline derivatives, their preparation and their therapeutic applicationSANOFI SA·Filed 2015·Granted Apr 18, 2017·0 cites·24 claims
- 2638US2023227428A1Amido compoundsAnaxis Pharma Pty Ltd·Filed 2021·Application pending·0 cites
- 2738US2017166555A1Functionalised and substituted indoles as anti-cancer agentsNovogen ltd·Filed 2014·Application pending·0 cites
- 2837US12215112B2CD151 inhibitorsEsfam Biotech Pty Ltd·Filed 2021·Granted Feb 4, 2025·0 cites·19 claims
- 2929US10793495B2Synthesis of polyaryl substituted aryl compoundsBOULOS & COOPER PHARMACEUTICALS PTY LTD·Filed 2016·Granted Oct 6, 2020·0 cites·21 claims
- 3023US10167292B2Benzodiazepines as bromodomain inhibitorsCATALYST THERAPEUTICS PTY LTD·Filed 2016·Granted Jan 1, 2019·0 cites·20 claims
- 3123US2018057465A1Inhibitors of NecroptosisCATALYST THERAPEUTICS PTY LTD·Filed 2016·Application pending·0 cites
- 3222US2017114025A1Methods for inhibiting necroptosisCATALYST THERAPEUTICS PTY LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Thomas Feutrill files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →